Nurse-Led Multi-Strain Probiotic Adjunctive Therapy in Patients with Colorectal Cancer: Effects on Psychological Distress, Inflammatory Responses, and Quality of Life

Main Article Content

Masniati Arafah, Aris Citra Wisuda, Kusman Ibrahim, Nursiswati, Fermata Sari, Desy Anggraini, Oril Ardianto, Logi Kiswanto

Abstract

Objective: To evaluate the effects of a nurse-led multi-strain probiotic adjunctive therapy on psychological distress, inflammatory responses, and quality of life in patients with colorectal cancer.


Methods: This quasi-experimental, two-group pretest–posttest study was conducted at RSUD Siti Fatimah Provinsi Sumatera Selatan, Palembang, Indonesia, from March to July 2026. A total of 70 patients with colorectal cancer were consecutively recruited and allocated to an intervention group receiving nurse-led multi-strain probiotic adjunctive therapy plus standard CRC care (n=35) or a control group receiving standard CRC care alone (n=35). Psychological distress, inflammatory biomarkers, and quality of life were assessed before and after the intervention. Between-group differences in outcome changes were evaluated using baseline-adjusted analyses.


Results: The intervention group demonstrated a greater reduction in psychological distress than the control group, with HADS scores decreasing from 16.9 ± 4.8 to 11.2 ± 4.1 versus 17.2 ± 5.1 to 15.3 ± 4.8, respectively. The between-group difference in mean change was −3.8 points (95% CI: −5.3 to −2.3; p<0.001). CRP, IL-6, and TNF-α decreased more substantially in the intervention group, with between-group differences of −2.8 mg/L (95% CI: −4.2 to −1.4; p<0.001), −2.7 pg/mL (95% CI: −4.2 to −1.2; p=0.001), and −1.7 pg/mL (95% CI: −2.6 to −0.8; p<0.001), respectively. Global health status improved by 10.9 points more than in the control group (95% CI: 6.6–15.2; p<0.001), with additional improvements in functional status and colorectal cancer-related symptoms.


Conclusion: Nurse-led multi-strain probiotic adjunctive therapy was associated with improvements in psychological distress, inflammatory responses, and quality of life among patients with colorectal cancer. These findings support its potential as a complementary component of holistic CRC care, although larger randomized controlled trials are warranted to confirm its effectiveness.

Article Details

Section
Articles